Drugs

Narrow Versus Broad Spectrum Antibacterials: Factors in the Selection of Pneumococcal Resistance to -Lactams
pp. 1289-1294(6)
Authors: Carbon C.; Isturiz R.

The Role of the Angiotensin System in Cardiac Glucose Homeostasis: Therapeutic Implications
pp. 1295-1314(20)
Authors: Bernobich E.; de Angelis L.; Lerin C.; Bellini G.

Combination Therapy for Malaria: The Way Forward?
pp. 1315-1329(15)
Authors: Nosten F.; Brasseur P.

Treatment of Heroin (Diamorphine) Addiction: Current Approaches and Future Prospects
pp. 1331-1343(13)
Authors: Gonzalez G.; Oliveto A.; Kosten T.R.

Olmesartan Medoxomil
pp. 1345-1353(9)
Authors: Warner G.T.; Jarvis B.

Olmesartan Medoxomil: A Viewpoint by Klaus O. Stumpe
pp. 1354-1356(3)
Author: Stumpe K.O.

Olmesartan Medoxomil: A Viewpoint by Danilo Fliser
pp. 1354-1356(3)
Author: Fliser D.

Olmesartan Medoxomil: A Viewpoint by Toshio Ogihara
pp. 1354-1356(3)
Author: Ogihara T.

Olmesartan Medoxomil: A Viewpoint by Gordon T. McInnes
pp. 1354-1356(3)
Author: McInnes G.T.

Gliclazide Modified Release
pp. 1357-1364(8)
Authors: McGavin J.K.; Perry C.M.; Goa K.L.

Gliclazide Modified Release: A Viewpoint by Andrew Harrower
pp. 1365-1366(2)
Author: Harrower A.

Gliclazide Modified Release: A Viewpoint by Pierre-Jean Guillausseau
pp. 1365-1366(2)
Author: Guillausseau P-J.

Perindopril: In Congestive Heart Failure
pp. 1367-1377(11)
Authors: Simpson D.; Noble S.; Goa K.L.

Perindopril: A Viewpoint by Professor J. R. Hampton
pp. 1378-1379(2)
Author: Hampton J.R.

Perindopril: A Viewpoint by Professor John G. F. Cleland
pp. 1378-1379(2)
Author: Cleland J.G.F.

Ramipril: A Review of its Use in the Prevention of Cardiovascular Outcomes
pp. 1381-1405(25)
Authors: Warner G.T.; Perry C.M.

Enoxaparin: An Update of its Clinical Use in the Management of Acute Coronary Syndromes
pp. 1407-1430(24)
Authors: Ibbotson T.; Goa K.L.